By Dennis Thompson HealthDay ReporterMONDAY, July 7, 2025 (HealthDay News) — Radiation therapy to treat cancer might be a ...

Corticosteroids, a commonly prescribed medication to alleviate cancer-related symptoms for non-small cell lung cancer ...

The treatment marks the only targeted oral treatment in patients with non–small cell lung cancer with epidermal growth factor ...

The FDA granted accelerated approval to the tyrosine kinase inhibitor sunvozertinib (Zegfrovy) for advanced non-small cell ...

A 79-year-old man with recurrent oropharyngeal cancer has developed the first documented case of severe drug-induced interstitial lung disease following photoimmunotherapy with cetuximab-sarotalocan ...

This newly launched program can save lives, with the proportion of cases identified at an early stage expected to rise from ...

Corticosteroids, a commonly prescribed medication to alleviate cancer-related symptoms for non-small cell lung cancer ...

From July, eligible Australians will be screened for lung cancer as part of the nation's first new cancer screening program ...

The new lung cancer screening program needs to be independently evaluated to keep it on track, and to minimise the harms.

AstraZeneca and its partner Daiichi Sankyo have won approval from U.S. regulators for their precision drug Datroway to treat ...

More cancer is being spotted sooner in a screening programme which has “flipped” statistics for patients’, NHS bosses were told.

During June, investigators reported new data that has advanced the treatment landscape for lung cancer, including new FDA ...